Better Choice Co Inc. Files S-1/A Amendment

Ticker: SRXH · Form: S-1/A · Filed: Jul 24, 2024 · CIK: 1471727

Sentiment: neutral

Topics: sec-filing, s-1/a, financials

TL;DR

Better Choice Co Inc. filed an S-1/A showing Q1 2024 revenue of $668,870. Financials updated.

AI Summary

Better Choice Co Inc. filed an S-1/A amendment on July 24, 2024, detailing its financial position. For the first quarter of 2024, the company reported $668,870 in revenue. The filing also provides balance sheet information as of December 31, 2023, and 2022, including common stock, additional paid-in capital, and retained earnings.

Why It Matters

This filing provides an updated look at Better Choice Co Inc.'s financial performance and position, which is crucial for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: medium — As an S-1/A filing, it indicates a company is in the process of offering securities, which inherently carries risks related to market conditions and the company's specific financial health.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this S-1/A filing?

This S-1/A filing is an amendment to a previous registration statement, likely to update information or provide further details regarding a securities offering by Better Choice Co Inc.

What was Better Choice Co Inc.'s revenue for the first quarter of 2024?

The filing indicates that Better Choice Co Inc. had $668,870 in revenue for the period ending March 31, 2024.

What financial data points are provided for the fiscal year end of 2023?

The filing includes data for common stock, additional paid-in capital, and retained earnings as of December 31, 2023.

When did the company change its name from Sport Endurance, Inc.?

The company's name was changed from Sport Endurance, Inc. on September 4, 2009.

What is the business address and phone number listed for Better Choice Co Inc.?

The business address is 12400 Race Track Road, Tampa, FL 33626, and the business phone number is 813-792-4352.

Filing Stats: 4,498 words · 18 min read · ~15 pages · Grade level 17.4 · Accepted 2024-07-23 19:53:07

Key Financial Figures

Filing Documents

FORWARD LOOKING STATEMENTS

FORWARD LOOKING STATEMENTS iii ABOUT THIS PROSPECTUS iv PROSPECTUS SUMMARY 1 THE OFFERING 3

USE OF PROCEEDS

USE OF PROCEEDS 23 DIVIDEND POLICY 24 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 25 CAPITALIZATION 26

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 28

BUSINESS

BUSINESS 39 MANAGEMENT 45 EXECUTIVE AND DIRECTOR COMPENSATION 49

SECURITY OWNERSHIP OF PRINCIPAL STOCKHOLDERS AND MANAGEMENT

SECURITY OWNERSHIP OF PRINCIPAL STOCKHOLDERS AND MANAGEMENT 55 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 55

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 56

UNDERWRITING

UNDERWRITING 61 LEGAL MATTERS 69 EXPERTS 69 WHERE YOU CAN FIND ADDITIONAL INFORMATION 69 i We have not, and the underwriter and their affiliates have not, authorized anyone to provide you with any information or to make any representation not contained or incorporated by reference in this prospectus or any related free writing prospectus. We do not, and the underwriter and its affiliates do not, take any responsibility for, and can provide no assurance as to the reliability of, any information that others may provide to you. This prospectus is not an offer to sell or an offer to buy common stock in any jurisdiction where offers and sales are not permitted. The information in this prospectus is accurate only as of its date, regardless of the time of delivery of this prospectus or any sale of common stock. You should also read and consider the information in the documents to which we have referred you under the caption "Where You Can Find More Information" in the prospectus. Neither we nor the underwriter have done anything that would permit a public offering of the common stock or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United of the common stock and the distribution of this prospectus outside of the United States. The information contained in this prospectus is accurate only as of its date, regardless of the time of delivery of this prospectus, or any free writing prospectus, as the case may be, or any shares of our common stock. Our business, results of operations, financial condition and prospects may have changed since that date. Before purchasing any securities, you should carefully read both this prospectus, together with the additional information described under the headings " Where You

business

business interruptions resulting from geopolitical actions, including war and terrorism; our ability to successfully implement our growth strategy; failure to achieve growth or manage anticipated growth; our ability to achieve or maintain profitability; the loss of key members of our senior management team; our ability to generate sufficient cash flow or raise capital on acceptable terms to run our operations, service our debt and make necessary capital expenditures; our dependence on our subsidiaries for payments, advances and transfers of funds due to our holding company status; our ability to successfully develop additional products and services or successfully market and commercialize such products and services; competition in our market; our ability to attract new and retain existing customers, suppliers, distributors or retail partners; allegations that our products cause injury or illness or fail to comply with government regulations; our ability to manage our supply chain effectively; our or our co-manufacturers' and suppliers' ability to comply with legal and regulatory requirements; the effect of potential price increases and shortages on the inputs, commodities and ingredients that we require, whether as a result of the continued actual or perceived effects of broader geopolitical and macroeconomic conditions, including the military conflict between Russia and Ukraine; our ability to develop and maintain our brand and brand reputation; compliance with data privacy rules; our compliance with applicable regulations issued by the U.S. Food and Drug Administration ("FDA"), the U.S. Federal Trade Commission ("FTC"), the U.S. Department of Agriculture ("USDA"), and other federal, state and local regulatory authorities, including those regarding marketing pet food, products and supplements; risk of our products being recalled for a variety of reasons, including product defects, packaging safety and inadequate or inaccurate label

Risk Factors

Risk Factors Investing in our common stock involves numerous risks, including the risks described under the heading " Risk Factors " in this prospectus and elsewhere in this prospectus. You should carefully consider these risks before making an investment. The following are some of these risks, any one of which could materially adversely affect our business, financial condition, results of operations, and prospects: Increases in sourcing, manufacturing, freight and/or warehousing costs, supply shortages, interruption in our sourcing operations and/or supply changes could have an adverse effect on our business, financial condition, and operating results; We may not be able to successfully implement our growth strategy or effectively manage our growth on a timely basis or at all; Our level of indebtedness and related covenants could limit our operational and financial flexibility and significant adversely affect our business if we breach such covenants and default on such indebtedness; If we do not successfully develop additional products and services, or if such products and services are developed but not successfully commercialized, our business will be adversely affected; Our ability to compete on the basis of product and ingredient quality, product availability, palatability, brand awareness, loyalty and trust, product variety and innovation, product packaging and design, reputation, price and convenience and promotional efforts in our highly competitive industry and against other industry participants, some of whom have greater resources than we do; We are vulnerable to fluctuations in the price and supply of key inputs, including ingredients, packaging materials, and freight; Food safety and food-borne illness incidents may materially adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings; Adverse litigation judgmen

View Full Filing

View this S-1/A filing on SEC EDGAR

View on Read The Filing